NTHI•benzinga•
Neonc Technologies Expects Full Enrollment In Phase 2a Clinical Trial For Lead Therapeutic Candidate, NEO100-01 In September
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 14, 2025 by benzinga